From the point on that we first reported that normal and malignant female reproductive organs express Epo and EpoR mRNA [6, 7], there has been accumulating evidence that the Epo-EpoR pathway is substantially involved in cancer progression [8–10]. The gene discussed is EPO; the disease is cancer.